The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | The evolving myeloma diagnosis criteria
Maria-Victoria Mateos, MD, PhD, from University Hospital of Salamanca, Salamanca, Spain; Faith Davies, MBBCh, MRCP, MD, FRCPath, from NYU Langone Medical Center, New York, NY, and Shaji Kumar, MD, from the Mayo Clinic, Rochester, Minnesota, discuss the changes in myeloma diagnosis criteria and the risk-stratification for smoldering myeloma. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA,
